SPLASH BEVERAGE GROUP, INC. — Form 8-K
Filed August 12, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 78/100
What the filing says
Splash Beverage Group (NYSE American: SBEV, market cap ~$6.5M) announced on August 12, 2026, that it will rebrand to Endovia Health Sciences effective August 24, 2026, with new ticker symbol EDVA. The pivot shifts the company from legacy beverage to a cannabinoid health sciences platform with three stated divisions: commercial pharmaceutical assets, FDA-regulated human/veterinary therapeutics, and consumer wellness beverages. The filing names Interim CEO Brady Cobb and references prior acquisitions of pharmaceutical IP and international partnerships over the past six months, but discloses no specific deal amounts, share counts, or financial metrics.
Why this rating
Fundamental business model transformation and capital redeployment is material for a $6.5M company; however, vague on concrete IP value, debt levels, and capital adequacy to execute plan. Execution risk high.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.